Marc Petersen‐Sylla

Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment

David Schnell, Susanne Buschke, Holger Fuchs et al. · Cancer Chemotherapy and Pharmacology · 2014 · 42 citations · Full text

Pharmacokinetics of serelaxin in patients with hepatic impairment: a single‐dose, open‐label, parallel group study

Zhanna Kobalava, S. V. Villevalde, Yu. V. Kotovskaya et al. · British Journal of Clinical Pharmacology · 2014 · 32 citations · Full text

Pharmacokinetics, Tolerability, and Safety of Murepavadin, a Novel Antipseudomonal Antibiotic, in Subjects with Mild, Moderate, or Severe Renal Function Impairment

Glenn E. Dale, Atef Halabi, Marc Petersen‐Sylla et al. · Antimicrobial Agents and Chemotherapy · 2018 · 30 citations · Full text

Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects

Shirin Bruderer, Marc Petersen‐Sylla, Margaux Boehler et al. · British Journal of Clinical Pharmacology · 2017 · 16 citations · Full text